As of March 31, 2026, Ravelcare Limited carries a market capitalization of 941.74M, placing it among publicly traded companies globally. Its enterprise value stands at 923.99M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 941.74M |
| Enterprise Value | 923.99M |
As of March 31, 2026, Ravelcare Limited has 6.86M shares outstanding.
| Shares Outstanding | 6.86M |
These figures are as of March 31, 2026.
| PB Ratio | 2.52 |
| P/TBV Ratio | 2.52 |
As of March 31, 2026, Ravelcare Limited maintains a current ratio of 4.42, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.42 |
| Quick Ratio | 0.62 |
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 21.50 |
These figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 107.44 |
As of March 31, 2026, Ravelcare Limited holds 17.75M in cash and equivalents against - - in total debt, resulting in a net debt position of -10.21M. Total book value stands at 374.09M, with working capital of 97.92M providing operational flexibility.
| Cash & Cash Equivalents | 17.75M |
| Net Debt | -10.21M |
| Equity (Book Value) | 374.09M |
| Book Value Per Share | 54.54 |
| Working Capital | 97.92M |
Already premium?